Stem Cells in Rapidly Evolving Active Multiple Sclerosis
clinical trial
Press Enter · cited answer in seconds
0 sources
Stem Cells in Rapidly Evolving Active Multiple Sclerosis
Summary
Stem Cells in Rapidly Evolving Active Multiple Sclerosis is a clinical trial[1].
Key Facts
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis is in the country of United Kingdom[2].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's instance of is recorded as clinical trial[3].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's start time is recorded as +2013-01-31T00:00:00Z[4].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's end time is recorded as +2016-07-31T00:00:00Z[5].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's sponsor is recorded as Imperial College London[6].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's main subject is recorded as multiple sclerosis[7].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's main subject is recorded as sclerosis[8].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+19'}[9].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's title is recorded as Stem Cells in Rapidly Evolving Active Multiple Sclerosis[10].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's short name is recorded as STREAMS[11].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's ClinicalTrials.gov ID is recorded as NCT01606215[13].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[14].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's clinical trial phase is recorded as phase I clinical trial[15].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's clinical trial phase is recorded as phase II clinical trial[16].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's research site is recorded as Imperial College Healthcare NHS Trust[17].
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis's study type is recorded as interventional study[18].